WELCURE DRUGS & PHARMACEUTICAL

BSE: 524661 30 Sep 2025

Healthcare

₹ 8.39

Welcure Drugs & Pharmaceuticals ltd specializes in Pharmaceuticals within the Healthcare sector.

WELCURE DRUGS & PHARMACEUTICAL

BSE: 524661 30 Sep 2025

Healthcare

₹ 8.39

Welcure Drugs & Pharmaceuticals ltd specializes in Pharmaceuticals within the Healthcare sector.

Book Value

9.11

Dividend Yield

0.0%

Debt to Equity

1.2

Stock P/E

2.46

Market Cap

68.2 Cr

WELCURE DRUGS & PHARMACEUTICAL - Share Price & Details

Market Cap

₹68.2

High /Low

15.9 / 6.06

Stock P/E

2.46

Book Value

₹9.11

Dividend Yield

0.0

ROCE

2.53

ROE

₹4.18

Face Value

10.0

PEG Ratio

0.01

EVEBITDA

₹5.37

Debt

123

CMP / FCF

-0.92

Debt to equity

₹1.2

NP Ann

2.17

High price all time

25.0

Piotroski score

₹4.0

Graham Number

22.5

No. Eq. Shares

11.2

Net CF

₹0.11

Net profit

27.7

Price to book value

0.67

Interest Coverage

₹NA

Low price all time

0.36

Industry PE

33.0

Reserves

₹-9.93

Free Cash Flow

₹-222

Broker Recommendations

No broker recommendations available

We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.

Price Chart

Volume Chart

Peer Comparison

Stock	Total Income	Net Profit	Net Sales	EPS	Market Cap (in Cr)	P/E
FABINO ENTERPRISES LIMITED	NA	NA	NA	NA	5.09	84.8
Triochem Products Ltd.,	NA	NA	NA	NA	0
WELCURE DRUGS & PHARMACEUTICAL	NA	NA	NA	NA	68.2	2.46
BIOFIL CHEMICALS & PHARMACEUTI	92.65	24.11	64.33	1.48	67.6	24.2
Concord Drugs Limited	NA	NA	NA	NA	66.2	154.0

Peer Comparison Chart

About WELCURE DRUGS & PHARMACEUTICAL

Welcure Drugs & Pharmaceuticals ltd, with Security Code 524661, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.

Order Book

Latest News

How Product Roadmap Could Affect Welcure Drugs Pharmaceuticals Limiteds Future Value - Swing Trading Ideas & Low Cost Capital Trading

(28 Sep 2025)

How Product Roadmap Could Affect Welcure Drugs Pharmaceuticals Limiteds Future Value ✌️【Investor Sentiment】✌️ Join thousands of investors...

Welcure Drugs & Pharmaceuticals - These 10 penny stocks plunged up to 55% in just a month — Are you affected?

(28 Sep 2025)

1-Month Performance: -44% | Previous Close: Rs 6.06 Welcure Drugs & Pharmaceuticals.

Welcure Drugs & Pharmaceuticals Hits New 52-Week Low at Rs. 6.09

(26 Sep 2025)

Welcure Drugs & Pharmaceuticals has hit a new 52-week low, continuing a downward trend with a significant decline over the past four days.

Welcure Drugs & Pharmaceuticals Hits New 52-Week Low at Rs. 6.37

(26 Sep 2025)

Welcure Drugs & Pharmaceuticals has hit a new 52-week low, reflecting a significant decline in its stock performance.

1:1 bonus share & 1:10 stock split: Penny stock hit upper circuit; Company executes LoI with Telexcell Trade Pte Ltd & increase total shareholding for FPIs and FIIs to 49%

(05 Sep 2025)

1:1 bonus share & 1:10 stock split: Penny stock hit upper circuit; Company executes LoI with Telexcell Trade Pte Ltd & increase total...

Telexcell Trade Pte to buy 25% in Welcure Drugs & Pharmaceuticals

(04 Sep 2025)

Welcure Drugs & Pharmaceuticals secures strategic investment from Telexcell Trade Pte to expand global footprint and research capabilities.

Quarterly Table

Standalone

Metrics	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.6	8.8	21.2
Expenses	0.0	0.1	0.0	0.1	0.1	0.1	0.3	22.7	7.9	20.5
Operating Profit	0.0	-0.1	0.0	-0.1	-0.1	-0.1	-0.3	1.8	0.9	0.7
OPM %	0%	0%	0%	0%	0%	0%	0%	7.51%	10.4%	3.38%
Other Income	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9
Interest	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Depreciation	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Profit before tax	0.0	0.2	0.0	-0.1	0.0	0.0	-0.3	1.8	0.9	2.6
Tax %	0%	0%	0%	0%	0%	0%	0%	0%	-54.6%	0%
Net Profit	0.0	0.2	0.0	-0.1	0.0	0.0	-0.3	1.8	0.4	2.5
EPS in Rs			0	-0.01	0	-0.01	-0.26	0.16	0.04	0

Shareholding Distribution

Shareholding Pattern

Compounded Data

Consolidated

Standalone

Compounded Sales Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	0%

Compounded Profit Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	18700%

Stock Price CAGR
10 Years:	25%
5 Years:	83%
3 Years:	26%
1 Year:	90%

Compounded Sales Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	4%

Compounded Profit Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	-124%

Stock Price CAGR
10 Years:	25%
5 Years:	83%
3 Years:	26%
1 Year:	90%

All Deals

Date	Stock	Party	Deal	Acq. Mode	Trans.	Quan.	Price	Value

Stock Mutual Funds Data

Order Book

News Date ▲▼	Headline ▲▼	Issuer Entity ▲▼	Issuer Type ▲▼	Order Size ▲▼	Time Period ▲▼
Loading company updates…

Loading technicals…

Moving Averages

Latest Close: — • Records Used: — • Last Trading Date: —

Simple Moving Averages (SMA)

Period	SMA Value	Status

Exponential Moving Averages (EMA)

Period	EMA Value	Status

Oscillators

Key Oscillators

latest calculation

Indicator	Value

WELCURE DRUGS & PHARMACEUTICAL

WELCURE DRUGS & PHARMACEUTICAL

WELCURE DRUGS & PHARMACEUTICAL - Share Price & Details

Broker Recommendations

Price Chart

Volume Chart

Peer Comparison

Peer Comparison Chart

About WELCURE DRUGS & PHARMACEUTICAL

Order Book

Latest News

How Product Roadmap Could Affect Welcure Drugs Pharmaceuticals Limiteds Future Value - Swing Trading Ideas & Low Cost Capital Trading

Welcure Drugs & Pharmaceuticals - These 10 penny stocks plunged up to 55% in just a month — Are you affected?

Welcure Drugs & Pharmaceuticals Hits New 52-Week Low at Rs. 6.09

Welcure Drugs & Pharmaceuticals Hits New 52-Week Low at Rs. 6.37

1:1 bonus share & 1:10 stock split: Penny stock hit upper circuit; Company executes LoI with Telexcell Trade Pte Ltd & increase total shareholding for FPIs and FIIs to 49%

Telexcell Trade Pte to buy 25% in Welcure Drugs & Pharmaceuticals

10:1 Stock Split & 1:10 Bonus Issue: Pharma Stock Locked in 5% Upper Circuit

Acquisition News: Singapore-based firm to buy 25% stake in this drug maker

Singapore-based firm proposes to acquire 25% in Welcure Drugs & Pharma

Welcure Drugs executes Letter of Intent with Telexcell Trade | Tap to know more | Inshorts

Welcure Drugs Hits Upper Circuit on ₹20 Stake Deal News

Welcure Drugs & Pharmaceuticals - These 9 penny stocks plunge up to 25% in just 4 trading sessions

Penny stock below ₹10 jumps 4% on THIS acquisition update by Singapore-based firm. Check details

1:10 Bonus Shares & 1:10 Stock Split Upcoming: Welcure Drugs Strengthens Global Footprint With Equity Deal

Welcure Drugs Hits Upper Circuit as Telexcell Trade Plans 25% Strategic Stake at ₹20 Per Share

Welcure Drugs: Singapore Firm to Acquire 25% Stake

Singapore-based firm proposes to acquire 25 pc in Welcure Drugs & Pharma

Telexcell Trade Eyes 25% Stake in Welcure Drugs to Expand Global Reach

Welcure Drugs & Pharmaceuticals Approves Bonus and Stock Split

Welcure Drugs & Pharma Board Clears Bonus Issue, Stock Split, ₹80 Crore QIP

Welcure Approves 1:10 Bonus, Stock Split & Capital Hike

Stock Split Share: 10 हिस्से में स्टॉक स्प्लिट साथ ही 10 पर एक शेयर का बोनस, तब भी लोअर सर्किट में फंसे

Welcure Drugs Reports Significant Sales Growth Amid Mixed Technical Indicators

Welcure Drugs & Pharmaceuticals Board Approves Bonus and Stock Split

Welcure Drugs & Pharmaceuticals board approves bonus and stock split

Welcure Drugs And Pharmaceuticals Share Price Update | Stock Market Today

Welcure Drugs and Pharmaceuticals Share Price Falls 5% as Board Approves Stock Split and Bonus Issue

1 बोनस शेयर देने का ऐलान, साथ ही 10 टुकड़ों में बंटेगा स्टॉक, ₹15 से कम है भाव

₹12 से कम कीमत वाला ये फार्मा स्टॉक 6 महीने में 66.86% चढ़ा, अब कंपनी ने स्टॉक स्प्लिट और बोनस शेयर देने का किया ऐलान

Welcure Board Approves 1:10 Bonus and 1:10 Stock Split; Authorised Capital Increase to ₹196 Crore

Small-cap multibagger stock declares 1:10 bonus shares, stock split in 1:10 ratio

Jackpot Incoming! 1:10 Stock Split & 1:10 Bonus Shares Announced: Is Welcure Drugs The Next Pharma Rocket?

Multibagger pharma penny stock at Rs 12 per share :...

Welcure Drugs & Pharma to set up agro-pharma lab for around Rs 80 crore

Stock Split + Bonus announcement on Friday: Pharma company announces Rs 80 cr investment plan; shares up 5%

Penny stock: फार्मा कंपनी की तरफ से ऐसी क्या सूचना आई कि शेयर रोज अपर सर्किट में फंसने लगे?

Welcure Drugs Reports Significant Sales Surge and Strong Financial Metrics Amid Market Challenges

Welcure Drugs & Pharma plans to invest ₹80 cr in research laboratory

Welcure Drugs to Set Up Agro-Pharma Lab

Penny stock: a pharma company share price hits 5% upper circuit, ; here's why

Pharma stock hits 5% upper circuit after announcing QIP of ₹80 Cr for expansion

Welcure Drugs & Pharmaceuticals Share Price Hits 5% Upper Circuit After New Project Update

Board of This Pharma Stock To Weigh 1:10 Stock Split, 1:1 Bonus Issue On Aug 22

Welcure Drugs & Pharma to Set Up Agro-Pharma Lab for Around ₹80 Cr

Welcure Drugs & Pharma to set up agro-pharma lab for around Rs 80 cr

Penny stock: Pharma company's share price hits 5% upper circuit; here's why

Multibagger pharma penny stock at Rs 12 per share : Plans Rs 80 Crore QIP to Fund Agro-Pharma Research Laboratory; Board is likely to announce 1:1 bonus share & 1:10 stock split

Welcure Drugs & Pharma board to consider share split, bonus issue this month

Welcure Drugs & Pharmaceuticals to consider stock split, bonus

Welcure Drugs & Pharmaceuticals Announces Proposal For Bonus Issue And Stock Split

1:10 Stock split, 1:1 bonus share: 100 shares will become 2000 - meeting on THIS date

Welcure Drugs to consider proposal for stock split and bonus issue

Shareholder Jackpot? Pharma Stock Proposes 1:10 Split And 1:1 Bonus To Woo Investors; Buy For Twin Treat?

Penny stock hits upper circuit after 1:10 stock split, 1:1 bonus shares move; details here

Multibagger pharma penny stock at Rs 10.59/share: Board is likely to announce 1:1 bonus share & 1:10 stock split

Welcure Drugs to hold board meeting over 1:1 bonus share issue | Tap to know more | Inshorts

Welcure Drugs & Pharmaceuticals Ltd posts robust Q1FY26 performance with Rs 23.29 crore net profit

Welcure Drugs & Pharmaceuticals posts Rs 23.29 crore profit for Apr-Jun quarter

This Multibagger Pharma Stock Hits 5% Upper Circuit- What Fueled Its Q1FY26 Result?

Penny Stock Hits Upper Circuit After Q1 Surge

Welcure Drugs & Pharmaceuticals posts Rs 23.29 cr profit for Apr-Jun quarter

Welcure Drugs & Pharma Shares Locks 5% Upper Circuit On Declaring Q1FY26 Results

Multibagger pharma stock: Shares hit 5% upper circuit after Q1 results; 697% RETURNS in 5 yrs

वेलक्योर ड्रग्स एंड फार्मास्युटिकल्स ने अप्रैल-जून तिमाही में दर्ज किया 23.29 करोड़ रुपये का लाभ

Welcure Drugs & Pharmaceuticals Reports Strong Financial Growth in June 2025 Results

Welcure Drugs & Pharmaceuticals reports standalone net profit of Rs 23.30 crore in the June 2025 quarter

Pharmaceuticals Limited (524661) Maintain Its Valuation - Phenomenal returns

Pharmaceuticals Limited (524661)’s Trend in 2025 - Unprecedented growth rates

Pharmaceuticals Limited (524661)’s Trend in 2025 - Unmatched market performance